LionBird — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Phantom Neuro develops neurotechnology for human-machine interaction, with a focus on applications for limb-loss and amputee populations.
AI & Machine LearningBiotechDeep TechMedical DevicesRoboticsAustin, US
Connor Glass(Executive Officer, Director, Promoter)in
BoardD.A. Wallach(Director)inEdward Michael(Director)in
Board seatRobert Lord· per SEC Form D
Co-investorsBreakout VenturesCapital FactoryCrosscourt VenturesDraper AssociatesGaingelsTime BioVentures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






__Twitter.png)
